End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.38 CNY | -3.73% | -0.76% | +17.21% |
Apr. 25 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Intco Medical Technology Co., Ltd. Proposes Final Dividend for 2023 | CI |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+17.21% | 2.55B | - | A- | |
+9.48% | 27.36B | B+ | ||
-30.75% | 3.13B | B- | ||
-16.72% | 2.54B | C+ | ||
-3.32% | 2.09B | - | ||
+7.78% | 2.08B | B | ||
+2.22% | 1.51B | B | ||
+0.46% | 1.32B | - | ||
+23.24% | 1.23B | C | ||
+3.72% | 1.14B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 300677 Stock
- Ratings Intco Medical Technology Co., Ltd.